Table 2 Cytokine response to different HCV peptides in studied groups (Kruskall Wallis)
From: TH1 cytokine response to HCV peptides in Egyptian health care workers: a pilot study
Group | Cytokine | Median cytokine (pg/ml) | p | |||
|---|---|---|---|---|---|---|
HCV PEPTIDES | ||||||
CORE | NS3 | NS4 | NS5 | |||
Positive PI HCW | IL2 | 16.855 | 36.18 | 17.405 | 20.18 | 0.209 |
IFN-γ | 2.16 | 11.4 | 3.31 | 2.0 | 0.662 | |
TNFα | 60.2 | 66.4 | 75.8 | 117 | 0.012* | |
Negative PI HCW | IL2 | 1.6 | 6.8 | 3.7 | 3.33 | 0.196 |
IFN-γ | .83 | 1.36 | 0 | 0.83 | 0.588 | |
TNFα | 14.8 | 157.4 | 30.4 | 79.5 | 0.168 | |
Chronic HCV HCW | IL2 | 10.9 | 16.1 | 8.7 | 28.33 | 0.807 |
IFN-γ | .065 | 0.35 | 0.28 | 0.175 | 0.583 | |
TNFα | 16.2 | 18.0 | 25. 8 | 20.3 | 0.989 | |